A significant advance in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently inactivated in several forms of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research